Emerging therapeutic targets for neuroblastoma
Author:
Affiliation:
1. University of Oklahoma Health Sciences Center, Oklahoma City, USA
2. Stephenson Cancer Center, Oklahoma City, USA
Funder
National Institutes of Health
Oklahoma Center for the Advancement of Science and Technology
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728222.2020.1790528
Reference167 articles.
1. Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group
2. Genetic susceptibility to neuroblastoma: current knowledge and future directions
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comprehensive integrated gene network construction to explore the essential role of Notch 1 in lung adenocarcinoma (LUAD);Journal of Biomolecular Structure and Dynamics;2024-01-28
2. Construction of methylation driver gene-related prognostic signature and development of a new prognostic stratification strategy in neuroblastoma;Genes & Genomics;2024-01-05
3. Cancer stem cell signaling in neuroblastoma progression—in touch with reality;Cancer Stem Cells and Signaling Pathways;2024
4. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo;Drug Delivery and Translational Research;2023-12-31
5. Target therapy for high-risk neuroblastoma treatment: integration of regulatory and scientific tools is needed;Frontiers in Medicine;2023-07-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3